These constructs typically link multiple distinct peptide epitopes—often encompassing different tumor-associated antigens (TAAs), CD4+ helper epitopes, and CD8+ cytotoxic T lymphocyte (CTL) epitopes—into a single polypeptide chain, sometimes separated by specific cleavable linkers or spacers [74,75]. Here, CD8A is linked to neoplasm.